Wat we doen

AMC Ventures Holding BV is opgericht in 1995 om het Academisch Medisch Centrum in staat te stellen via participaties maatschappelijke en economische meerwaarde te creëren uit onderwijs en onderzoek, zónder dat publiek en privaat geld wordt vermengd. Doelstelling is om middels de spin off route bij te dragen aan een product voor de patiënt op basis van AMC onderzoek en het genereren van waarde door dividend of exit welke dan terugvloeit naar het Academisch Medisch Centrum.

AMC Ventures Holding BV stimuleert en faciliteert ondernemerschap, investeert in new ventures en beheert aandelenbelangen. We verzorgen voor verschillende ondernemingen governance, finance & control, management en advies. Dit doen we ook voor ondernemingen van UvA Ventures Holding BV en HvA Ventures Holding BV, de holdings van de Universiteit van Amsterdam (UvA) en de Hogeschool van Amsterdam (HvA).

De gemeenschappelijke portfolio van AMC Ventures Holding BV, UvA Ventures Holding BV en HvA Ventures Holding BV is onderverdeeld in 3 categorieën: New Ventures, Contractonderzoek en Services. Alle ondernemingen van AMC Ventures Holding BV horen bij de categorie New Ventures.

Nieuws

2 oktober 2023

Amsterdam UMC spin-off inSteps launched

inSteps, an Amsterdam UMC spin-off, has officially been incorporated. Fueled by in-silico modeling technology, the company’s mission is to advance crucial treatment for severe strokes. inSteps was founded by Prof. Henk Marquering, Dr. Praneeta Konduri, Dr. Nerea Arrarte Terreros and Dr. Thomas Kerbusch from the Amsterdam UMC Departments of Radiology & Nuclear Medicine, Biomedical Engineering & Physics, together with AMC Ventures Holding B.V.

Lees verder

12 september 2023

AMI BV ontvangt financiering van het Innovatiefonds Noord-Holland

Advanced Microbiome Interventions (AMI) B.V heeft een converteerbare lening van €300.000 ontvangen van het Innovatiefonds Noord-Holland. AMI BV onderzoekt en ontwikkelt innovatieve geneesmiddelen voor type 1 diabetes en andere auto-immuunziekten. Dit zijn complexe ziekten waarvoor nog geen medicijnen zijn gevonden met alleen in Nederland al meer dan honderdduizend type 1 diabetes patiënten. 

Lees verder

Bekijk meer nieuws

Een aantal veelgestelde vragen

1. Why AMC Ventures Holding BV?

AMC Ventures Holding BV, established in 1995, is a 100% subsidiary of the Academic Medical Center (AMC). It facilitates top researchers from the AMC in their attempts to set up companies based on their scientific findings in the area of medical Research & Development or production arising from this. At the same time, with its activities, AMC Ventures Holding B.V. implements the AMC’s valorisation policy, which is promoting the use of scientific knowledge for the benefit of patients, for the development of e.g. a new medicine, medical device or diagnostic method.

2. Why start a startup company at the AMC?

Valorisation is the fourth mission of the AMC. This concerns activities that add value to the scientific knowledge beyond the academic domain. For researchers, seeing a product based on their invention enter the market and benefit patients is very rewarding. One of the routes from research results to a product is via development in a startup company. This route is taken when established companies are not interested enough yet to license the technology (due to it still being at an early stage), the AMC (IXA) believes in the potential of the technology, the technology is within the core interests of the AMC, and the researchers are enthusiastic about setting up a startup company.
To support the growth of startups that utilize university IP or know how and to separate public funding and private revenue streams, AMC took the initiative to set up AMC Ventures Holding BV.

3. What can AMC Ventures Holding do for you?

Scientists / Doctors
AMC Ventures teams up with the inventor(s) when it comes to commercialising the findings and provides feedback on the business model, together with the Technology Transfer Office of the AMC, IXA. On founding a startup, AMC Ventures establishes the legal, financial and governance structures of the company, for example drafting the shareholders agreement, statutes and setting up the financial administration. The extent of support depends on the extent of participation of AMC Ventures in the startup, which can vary over time. AMC Ventures also has an active role in finding new team members, esp. those with business development, financial modelling and marketing skill sets.

Entrepreneurs
AMC Ventures is always on lookout for entrepreneurs for its portfolio companies. Please contact Ross Gordon for more information. Are you interested in technologies or research domains at the AMC? Please contact IXA.

Investors
Are you interested in AMC Ventures’ portfolio companies? Please contact Ross Gordon.

Students
Students interested in working at a startup can contact the UvA Ventures portfolio company StudiJob

4. What are the portfolio companies of AMC Ventures Holding?

The AMC Ventures portfolio companies are as diverse as the disciplines at the AMC. An overview of all AMC Ventures can be found in the combined portfolio of AMC Ventures Holding, UvA Ventures Holding and HvA Ventures Holding. They form part of the ‘New Ventures’ category.

5. How does founding an AMC startup work?

The beginning
A scientist with an invention should first contact IXA Office AMC. IXA is AMC’s department responsible for commercialising scientific knowledge. IXA (through its business developers and patent attorney) a.o. advises on the most suitable valorisation route, takes care of patent filing, negotiates licensing and research collaboration contracts with external and startup companies, and provides proof-of-concept funding in collaboration with AMC Ventures.

From founding onwards
After the startup is founded, AMC Ventures guides the startup through establishing a legal, financial and governance structure as already eluded on in section 3. In addition AMC Ventures also supports funding, launching customer, prototyping etc.